Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases

Published:2011-11-17 Issue:11 Volume:6 Page:e27970
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhang Xiaotun,Morrissey Colm,Sun Shihua,Ketchandji Melanie,Nelson Peter S.,True Lawrence D.,Vakar-Lopez Funda,Vessella Robert L.,Plymate Stephen R.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Molecular determinants of resistance to antiandrogen therapy.;CD Chen;Nature Med,2004

2. Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.;RB Montgomery;Cancer Res,2008

3. Androgen levels increased by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.;JA Locke;Cancer Res,2008

4. Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.;EA Mostaghel;Cancer Res,2007

5. Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells.;X Yuan;Am J Pathol,2006

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AR-V7 expression facilitates accelerated G2/M phase transition in castration-resistant prostate cancer;Experimental Cell Research;2024-05

2. Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype;Cell Reports;2023-12

3. Therapeutic implications of cancer stem cells in prostate cancer;Cancer Biology & Medicine;2023-06-05

4. Androgen receptor signaling mechanism in prostate cancer: resistance to antiandrogen therapy and association with DNA repair genes;Cancer Urology;2023-05-13

5. Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer;Pharmaceuticals;2023-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3